Quantum Biopharma (QNTM) Enterprise Value (2018 - 2026)
Quantum Biopharma (QNTM) posted Enterprise Value of -$6.6 million for Q1 2026, down 57.18% sequentially from -$4.2 million in Q4 2025, and down 38.74% YoY from -$10.7 million in Q1 2025.
Quantum Biopharma (QNTM) Enterprise Value (2018 - 2026) Analysis & Trends
Quantum Biopharma has reported Enterprise Value for 9 years, with the latest figure at -$6.6 million in Q1 2026.
- Quarterly Enterprise Value fell 38.74% year-over-year to -$6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.6 million (down 38.74% YoY) and the FY2025 annual result came in at -$4.2 million, up 49.19% from the prior year.
- Enterprise Value declined to -$6.6 million in Q1 2026 per QNTM's latest filing, from -$4.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$2.2 million in Q3 2025 and troughed at -$32.0 million in Q2 2022.
- A 5-year average of -$10.9 million and a median of -$6.6 million in 2026 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 81.49% in 2023, then tumbled 69.17% in 2024.
- Over 5 years, Enterprise Value stood at -$17.0 million in 2022, then surged by 73.72% to -$4.5 million in 2023, then tumbled by 84.59% to -$8.2 million in 2024, then surged by 49.19% to -$4.2 million in 2025, then plunged by 57.18% to -$6.6 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$6.6 million, -$4.2 million, and -$2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 2.12 Bn |
| 10 | Quantum Biopharma | 15.49 Mn | 11.84 Mn | - | -3.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.86 Mn |
| Mar 31, 2026 | -6.58 Mn |
| Dec 31, 2025 | -4.19 Mn |
| Sep 30, 2025 | -2.23 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Mar 31, 2025 | -4.74 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Sep 30, 2024 | -7.55 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Sep 30, 2023 | -4.46 Mn |
| Jun 30, 2023 | -6.22 Mn |
| Mar 31, 2023 | -9.87 Mn |
| Dec 31, 2022 | -16.98 Mn |
| Sep 30, 2022 | -24.11 Mn |
| Jun 30, 2022 | -31.98 Mn |
| Mar 31, 2022 | -29.11 Mn |
| Dec 31, 2021 | -35.42 Mn |
| Sep 30, 2021 | -40.81 Mn |
| Jun 30, 2021 | -45.45 Mn |
| Mar 31, 2021 | -52.48 Mn |